LPTX Leap Therapeutics, Inc. - 8-K

Item 8.01

Other Information.

As previously reported, on March 4, 2026,
Cypherpunk Technologies Inc. (the “Company”) received a notification letter (the “Closing Bid Price Deficiency Letter”)
from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing
bid price of the Company’s common stock had fallen below $1.00 per share for 30 consecutive business days, the Company no longer
met the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). On May 21, 2026, the Company received a letter from
Nasdaq notifying the Company that it had regained compliance with Nasdaq Listing Rule 55520(a)(2), and the matter is now closed.

9.01

Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Description

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).